Amphastar Pharmaceuticals (FRA:29A) FCF Margin % : 27.06% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Amphastar Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Amphastar Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2024 was €42.8 Mil. Amphastar Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was €158.1 Mil. Therefore, Amphastar Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 27.06%.

As of today, Amphastar Pharmaceuticals's current FCF Yield % is 7.99%.

The historical rank and industry rank for Amphastar Pharmaceuticals's FCF Margin % or its related term are showing as below:

FRA:29A' s FCF Margin % Range Over the Past 10 Years
Min: -2.92 Med: 4.2 Max: 23.85
Current: 23.85

During the past 13 years, the highest FCF Margin % of Amphastar Pharmaceuticals was 23.85%. The lowest was -2.92%. And the median was 4.20%.

FRA:29A's FCF Margin % is ranked better than
93.57% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.25 vs FRA:29A: 23.85

Amphastar Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Amphastar Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals FCF Margin % Chart

Amphastar Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

0.06

6.69

16.11

13.06

22.55

Amphastar Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															22.07	31.48	29.99	8.10	27.06

Competitive Comparison of Amphastar Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amphastar Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's FCF Margin % falls into.

Amphastar Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Amphastar Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	133.274	/	590.91
	=	22.55 %

Amphastar Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	42.778	/	158.089
	=	27.06 %

Amphastar Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Amphastar Pharmaceuticals (FRA:29A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (FRA:29A) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AMPH:USA 29A:Germany

Address

11570 6th Street, Rancho Cucamonga, CA, USA, 91730

Website

http://www.amphastar.com

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals (FRA:29A) Headlines

No Headlines